SCHEMBL5589813

SCHEMBL5589813

CCc1ccc(N=C(C)c2cccc(C(C)=Nc3ccc(CC)cc3C(C)C)n2)c(C(C)C)c1.[Co]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.42
CYP1A2 P05177 3/20 0.35
CYP2A6 P11509 1/20 0.35
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
MAPK1 P28482 1/20 0.30
ALDH1A1 P00352 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
CYP2D6 P10635 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
MEN1 O00255 1/20 0.30
HTT P42858 1/20 0.30
RAD52 P43351 1/20 0.30
KMT2A Q03164 1/20 0.30
TP53 P04637 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589352 0.99 SIGMAR1 (0.43) SIGMAR1CYP1A2CYP2A6NOS3NOS1
SCHEMBL5590427 0.84 SIGMAR1 (0.36) SIGMAR1CYP1A2CYP2A6
SCHEMBL5586653 0.82 SIGMAR1 (0.39) SIGMAR1CYP1A2CYP2A6MAPK1ALDH1A1
SCHEMBL5587396 0.82 TRPA1 (0.37) SIGMAR1CYP1A2ALDH1A1SMN1; SMN2NPC1
SCHEMBL5588761 0.82 SIGMAR1 (0.36) SIGMAR1CYP1A2CYP2A6TSHR
SCHEMBL5588276 0.81 TRPA1 (0.38) SIGMAR1CYP1A2ALDH1A1SMN1; SMN2NPC1
SCHEMBL5588047 0.81 SIGMAR1 (0.39) SIGMAR1CYP1A2CYP2A6MAPK1ALDH1A1
SCHEMBL5588043 0.81 SIGMAR1 (0.39) SIGMAR1CYP1A2CYP2A6MAPK1ALDH1A1
SCHEMBL8094733 0.80 MAPT (0.35) NOS3NOS1NOS2MAPK1ALDH1A1
SCHEMBL8094736 0.80 MAPT (0.35) NOS3NOS1NOS2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 SIGMAR1 1143/4885CYP1A2 2390/4885CYP2A6 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.